Core Scientific Investors Resist CoreWeave’s $9 Billion Merger Bid

Core Scientific shareholders are mounting opposition to CoreWeave's proposed acquisition, arguing the $9 billion deal significantly undervalues the Bitcoin mining firm. Dissenting investors may block the transaction unless terms are revised, with a shareholder vote anticipated this fall.

The contested offer values Core Scientific at $20.40 per share based on CoreWeave's July 2025 stock price, but WOULD dilute existing shareholders to less than 10% ownership. Legal investigations have been launched to assess whether the 0.1235 share exchange ratio fairly compensates CORZ investors.

While the specific objections remain undisclosed, the deal's purported benefits include eliminating $10 billion in future lease obligations. The standoff highlights growing tensions as crypto infrastructure firms navigate consolidation in a rebounding market.